Pancreatectomy with resection of the portal vein and/or superior mesenteric vein, along with jejunal vein resection, is a safe procedure for patients with pancreatic ductal adenocarcinoma. The study found that postoperative complications and mortality rates were similar across all groups. Overall survival did not significantly differ between patients who underwent pancreatectomy with portal vein and/or superior mesenteric vein resection alone and those who had jejunal vein resection as well. Adjuvant therapy and achieving complete resection were identified as independent factors affecting survival.
Journal Article by Nagakawa Y, Jang JY (…) Endo I et 22 al. in Ann Surg
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.